242
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Correlation of White Blood Cell, Neutrophils, and Hemoglobin with Metabolic Syndrome and Its Components

, , , , &
Pages 1347-1355 | Received 10 Feb 2023, Accepted 29 Apr 2023, Published online: 10 May 2023

References

  • Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z
  • Wu Z, Jiang Y, Zhou D, et al. Sex-specific association of subclinical hypothyroidism with incident metabolic syndrome: a population-based cohort study. J Clin Endocrinol Metab. 2022;107(6):e2365–e2372.
  • Yang Y, Jung GM. Metabolic syndrome as a risk factor for gastric cancer by gender. Iran J Public Health. 2022;51(1):216–218.
  • Righetto M, Modonutti D, Celso FG, Fulcoli V, Mancini M. Metabolic syndrome and bladder cancer. Panminerva Med. 2022;64(3):316–323.
  • Chang CW, Ke HL, Lee JI, et al. Metabolic syndrome increases the risk of kidney stone disease: a cross-sectional and longitudinal cohort study. J Pers Med. 2021;11(11):54.
  • O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.
  • Yao F, Bo Y, Zhao L, et al. Prevalence and influencing factors of metabolic syndrome among adults in China from 2015 to 2017. Nutrients. 2021;13:12.
  • Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med. 2021;42(3):199–214.
  • Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):w56.
  • Seo I-H, Lee Y-J. Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical settings: a comprehensive literature review. Biomedicines. 2022;10(11):2697. doi:10.3390/biomedicines10112697
  • Yang H, Fu Y-Q, Yang B, et al. Positive association between the metabolic syndrome and white blood cell counts in Chinese. Asia Pac J Clin Nutr. 2017;26(1):141–147. doi:10.6133/apjcn.102015.13
  • Hashemi Moghanjoughi P, Neshat S, Rezaei A, Heshmat-Ghahdarijani K. Is the neutrophil-to-lymphocyte ratio an exceptional indicator for metabolic syndrome disease and outcomes? Endocr Pract. 2022;28(3):342–348.
  • Adams-Huet B, Jialal I. The neutrophil count is superior to the neutrophil/lymphocyte ratio as a biomarker of inflammation in nascent metabolic syndrome. Ann Clin Biochem. 2019;56(6):715–716.
  • Lin HY, Zhang XJ, Liu YM, Geng LY, Guan LY, Li XH. Comparison of the triglyceride glucose index and blood leukocyte indices as predictors of metabolic syndrome in healthy Chinese population. Sci Rep. 2021;11(1):10036.
  • He S, Gu H, Yang J, Su Q, Li X, Qin L. Hemoglobin concentration is associated with the incidence of metabolic syndrome. BMC Endocr Disord. 2021;21(1):53.
  • Yang XJ, Zhang LY, Ma QH, et al. Platelet parameters in Chinese older adults with metabolic syndrome. Endocr Connect. 2020;9(7):696–704.
  • Jialal G, Adams-Huet B, Jialal I. Both the platelet count and the platelet: lymphocyte ratio are not increased in nascent metabolic syndrome. Platelets. 2019;30(8):1057–1058.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
  • Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chine J Diabetes Mellitus. 2021;13(4):315–409.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
  • Yu S, Guo X, Li G, Yang H, Zheng L, Sun Y. Lymphocyte to high-density lipoprotein ratio but not platelet to lymphocyte ratio effectively predicts metabolic syndrome among subjects from rural China. Front Cardiovasc Med. 2021;8:583320.
  • McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14–20.
  • Song QB, Zhao Y, Liu YQ, Zhang J, Xin SJ, Dong GH. Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: the CHPSNE study. Diab Vasc Dis Res. 2015;12(3):189–198.
  • Al-Daghri NM, Al-Shuwaie AYA, Alghamdi A, et al. Tristetraprolin, inflammation, and metabolic syndrome in Arab adults: a case control study. Biology. 2021;10:6.
  • Zhou W, Li CL, Cao J, Feng J. Metabolic syndrome prevalence in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease: relationship with systemic inflammation. Clin Respir J. 2020;14(12):1159–1165.
  • Ryder E, Diez-Ewald M, Mosquera J, et al. Association of obesity with leukocyte count in obese individuals without metabolic syndrome. Diabetes Metab Syndr. 2014;8(4):197–204.
  • Yang XJ, Tian S, Ma QH, Sun HP, Xu Y, Pan CW. Leukocyte-related parameters in older adults with metabolic syndrome. Endocrine. 2020;68(2):312–319.
  • Zhou P, Meng Z, Liu M, et al. The associations between leukocyte, erythrocyte or platelet, and metabolic syndrome in different genders of Chinese. Medicine. 2016;95(44):e5189.
  • Hedayati MT, Montazeri M, Rashidi N, et al. White blood cell count and clustered components of metabolic syndrome: a study in western Iran. Caspian J Intern Med. 2021;12(1):59–64.
  • Bahadır A, Baltacı D, Türker Y, et al. Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol. 2015;15(10):816–822.
  • Najafzadeh MJ, Baniasad A, Shahabinejad R, Mashrooteh M, Najafipour H, Gozashti MH. Investigating the relationship between haematological parameters and metabolic syndrome: a population-based study. Endocrinol Diabetes Metab. 2023;6(2):e407.
  • Hashimoto Y, Tanaka M, Kimura T, et al. Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study. Endocrine. 2015;50(2):390–396.
  • Chung GE, Yim JY, Kim D, et al. Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease. Dig Liver Dis. 2017;49(1):57–62.
  • Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism. 1994;43(4):423–427.
  • Abdel-Moneim A, Mahmoud B, Sultan EA, Mahmoud R. Relationship of leukocytes, platelet indices and adipocytokines in metabolic syndrome patients. Diabetes Metab Syndr. 2019;13(1):874–880.
  • Fang KC, Cheng YL, Su CW, et al. Higher platelet counts are associated with metabolic syndrome independent of fatty liver diagnosis. J Chin Med Assoc. 2017;80(3):125–132.
  • Collado A, Marques P, Escudero P, et al. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders. Cardiovasc Res. 2018;114(13):1764–1775.
  • Fan GQ, Qin RR, Li YH, et al. Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome. Oncotarget. 2016;7(50):83231–83240.